| 1例肝硬化合并胸腔积液患者的抗感染治疗及药学监护 |
| 投稿时间：2013-07-30 修订日期：2014-02-20 点此下载全文 |
| 引用本文：曹喜红,薛培丽,张丽丽.1例肝硬化合并胸腔积液患者的抗感染治疗及药学监护[J].药学实践杂志,2014,32(6):462~464 |
| 摘要点击次数: 1124 |
| 全文下载次数: 113 |
|
|
| 中文摘要:目的 临床药师通过参与临床药物治疗,对患者进行药学监护,探讨临床药师在临床治疗中的价值。方法 结合1例肝硬化合并胸腔积液患者,参与治疗方案的制订,对患者进行用药教育,跟踪疗效及不良反应。结果 临床药师参与临床用药,实施药学监护,可以提高药物治疗效果,减少药物不良反应的发生。结论 临床药师的参与,可使临床用药更加规范合理,具有一定的参考价值。 |
| 中文关键词:肝硬化 胸腔积液 药学实践 |
| |
| Anti-infection treatment and pharmaceutical care for one patient of liver cirrhosis complicated with pleural effusion |
|
|
| Abstract:Objective To investigate the value of clinical pharmacists in clinical treatment through the practice of clinical pharmacists participating in clinical drug treatment and providing pharmaceutical care to patients.Methods Clinical pharmacists were involved in therapeutic scheme making, medication education and drug effect and adverse reaction tracking of one patient of liver cirrhosis complicated with pleural effusion.Results The effects of drug treatment were improved and the adverse drug reactions were reduced after the participation of pharmacist in clinical treatment and the implementation of pharmaceutical care for the patient.Conclusion The participation of pharmacist in clinical drug therapy could enhance normative and reasonable usage of drugs. This participation is decisive and valuable in clinical treatment. |
| keywords:liver cirrhosis pleural effusion pharmaceutical practice |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
|
|
|
